The Need

Gene-modified cell therapies are the most effective platform for treating many patients with advanced disease. Despite this, these therapies are limited to minute fraction of patient populations due to inefficient development and limited manufacturing scales.

Gene-modified cell therapies are the most effective platform for treating many patients with advanced disease. Despite this, these therapies are limited to a minute fraction of patient populations due to inefficient development and limited manufacturing scales

 

Work with us!

  • ACADEMIC PILOT Let us help you accelerate therapeutic discovery.

  • CO-DEVELOPMENT Discovery phase complete? We can also accelerate therapeutic development.

  • MANUFACTURING Coming soon! Our hardware is made exclusively with regulatory-approved materials and can be readily-engineered for gene-modified cell therapy manufacturing.

 

The state of gene therapies now

MORE THAN 250 CLINICAL TRIALS AND 100 INDs FOR EMERGING CANCER CELL THERAPIES

MANUFACTURING SCALES ARE LIMITED TO THOUSANDS OF PATIENTS

VIRUSES AND ELECTROPORATION ADVERSLY AFFECT HUMAN PRIMARY IMMUNE CELLS

MOST MICROFLUIDIC GENE DELIVERY TECHNOLOGIES HAVE LIMITED THROUGHPUT